Click on the titles below to read recent CRI press releases.

If you would like to interview CRI experts, researchers and scientific partners mentioned in these items below, we would be happy to assist you. Please contact Brian M. Brewer, Director of Communications, at 212-688-7515, ext. 242 or bbrewer@cancerresearch.org.

Recent Press Releases & Announcements:

2011

• Lloyd J. Old, M.D., "Father of Modern Tumor Immunology," Dies (2011.11.28)
• Critical Value Demonstrated for Immune Assay Harmonization (2011.11.09)
• Cancer Immunotherapy Consortium Appoints New Leadership (2011.11.09)
• 25th Annual CRI Awards Dinner Honors Outstanding Contributions to Tumor Immunology (2011.10.21)
• Collaborative Partnership Pioneers Model to Improve Clinical Success of Cancer Immunotherapies (2011.10.18)
• Three Cancer Research Institute Scientists to Receive the 2011 Nobel Prize (2011.10.04)
• Cancer Research Institute Announces Historic Change in Scientific Leadership (2011.10.03)
• Cancer Vaccine Collaborative Clinical Trials Network Appoints New Director, Expands Leadership (2011.09.22)
• Cancer Research Institute to Honor Former Postdoctoral Fellow at 25th Annual Awards Dinner (2011.09.08)
• Cancer Research Institute to Honor Pioneers in Adoptive Immunotherapy (2011.09.01)
• Mitchell H. Gold, CEO of Dendreon Corporation, to Receive 2011 Oliver R. Grace Award (2011.08.17)
• Cancer Research Institute Announces New Programs (2011.07.25)
• Cancer Research Institute Awards $9.7 Million in Grants to Support Immunology and Tumor Immunology Research (2011.07.06)
• PUBLICATION: Cancer Immunotherapy Expert Roundtable Report (2011.06.30)
• Hollywood Producer and Cancer Activist Laura Ziskin Dies of Breast Cancer (2011.06.13)
• MEDIA ALERT: 29th Annual Through the Kitchen Benefit Raises $692,000 for Cancer Research Institute (2011.04.18)
• MEDIA ALERT: 29th Annual Through The Kitchen Benefit for Cancer Research Institute (2011.04.13)
• New Perspectives on Cancer and the Immune System (2011.03.25)
• FDA Approves Ipilimumab, an Immunotherapy, for Metastatic Melanoma (2011.03.25)
• Cancer Immunotherapy Consortium to Host Conference on Scheduling and Dosing for Combination Therapy (2011.03.09)
• Cancer Research Institute and Oncovir Partner to Manufacture Powerful Immune Stimulant Poly-ICLC (Hiltonol®) (2011.01.21)   
  

2010

• Cancer Research Institute Announces Launch of Cancer Vaccine Acceleration Fund (2010.12.14) 
• MIATA Project Joint Position Paper Published (2010.11.22)
• CRI Scientists Propose New Endpoints to Improve Cancer Immunotherapy Clinical Trials (2010.09.23)
• CRI Investigator Vincenzo Cerundolo Named to Top Position at U.K. Immunology Research Group (2010.07.21)
• MEDIA ALERT: Michael Kors to Receive Cancer Service Award, Actress Joan Allen Presenting (2010.06.11)
• New Cancer Immunotherapy Helps Patients with Metastatic Melanoma Live Longer (2010.06.07) 
• CRI Announces 2010 William B. Coley Award Winners (2010.06.07)
• FDA Approval of Provenge, a Therapeutic Vaccine for Prostate Cancer, a Milestone Victory for the Field (2010.04.30)
• MEDIA ALERT: 28th Annual Through the Kitchen Party at The Four Seasons to Benefit Irvington Fellowship Program of the Cancer Research Institute (2010.04.13)
• CRI Scientists Develop Novel Technology to Assess Cancer Vaccine-Induced CD4+ T-cell Response (2010.04.07)
• Cancer Vaccine Consortium Changes Name to Cancer Immunotherapy Consortium (2010.03.18)
• 2010 Oliver R. Grace Award Winners Announced (2010.03.15)
• Report from the Laboratory: Cancer Seromics - New Dimensions in the Analysis of the Immune Response to Cancer (2010.03.01) 
• Report from the Laboratory: CT45, an Unexpected Link between Hodgkin Lymphoma and Reproductive Germ Cells (2010.02.24)
• CRI Executive Director Appears in Health Matters at Work® Video Podcast Series from Community Health Charities of America (2010.02.17)
• MEDIA ALERT: Young Philanthropists Spring Into Style at Saks Fifth Avenue Event to Benefit Cancer Research Institute (2010.02.16)

2009 

• Targeting Normal Cells in Tumors Can Slow Tumor Growth Like Taking Soil from the Seed (2009.11.16)
• Hundreds of Genes Distinguish Patients Likely to Survive Advanced Melanoma (2009.11.10)
• HPV Vaccine Clears Viral Infection and May Reduce Cancerous Lesions (2009.11.09)
• MIATA Project Announced: Minimal Information About T cell-Based Immune Monitoring Assays (2009.10.20)
• CRI Postdoctoral Fellow Helps Discover How Bizarre Bacteria Balance the Immune System in Mice (2009.10.15)
• Harvard Researcher Wins Immunology Award from the Cancer Research Institute (2009.10.06)
• Symposium to Highlight Strategies to Overcome Cancer Immunosuppression During Cancer Therapy (2009.09.29)
• Stenbeck Foundation Gives $1 Million to CRI for Ovarian Cancer Research Efforts (2009.09.21)
• Cancer Vaccine Produced at Non-Commercial Facility Enters Clinical Trials (2009.08.13)
• EXPERT AVAILABLE - FDA Issues Warning on Link of Tumor Necrosis Factor to Cancer Risk (2009.08.07)
• NYC "Midsummer Social" Benefit for Young Philanthropists Raises $25,000 for the Cancer Research Institute (2009.08.07)
• 2009 Coley and Grace Award Winners Announced, to be Honored at June 11 Gala in New York City (2009.05.29)
• CRI Employee Wins Top Service Award from Community Health Charities of America (2009.05.08)
• "Through the Kitchen" Dinner Raises a Half-Million Dollars to Support Cancer Research Institute (2009.05.07)
• New Organizational Structures Required to Translate Basic Science into Clinical Application Says CRI Scientific Director (2009.05.03)
• EXPERT AVAILABLE - Provenge® Prostate Cancer Vaccine Heralds New Dawn in Cancer Therapy (2009.04.29)
• CRI Scientists Improve the Immune Response to Cancer (2009.04.27)
• MEDIA ALERT - "Through the Kitchen" Benefit at The Four Seasons - May 3, 2009 (2009.04.21)
• Forbes Magazine's "Cancer Miracles" a CRI Success: A Response from CRI's Executive Director (2009.02.16) 
• Immune Response Linked to 'Cancer Miracles' Says Forbes Magazine Cover Story (2009.02.11)
• CRI Fellow’s Findings Will Rewrite Textbooks, CRI Scientific Advisors Say (2009.02.02)
• New York's Cancer Vaccine Collaborative is Named Finalist for National Nonprofit Collaboration Prize (2009.01.15)

2008

• CRI Receives Charity Navigator's Highest Rating (2008.09.26)
• Young Philanthropists "A New Force for Good" to Benefit Cancer Research Institute (2008.08.07)
• Cancer Research Institute Names Six New Investigator Award Winners (2008.08.04)
• 16 Outstanding Young Scientists Named to Receive CRI Postdoctoral Fellowship Award (2008.07.31)
• CRI Announces 2008 Grace and Coley Award Winners (2008.05.27)
• Three CRI Researchers Elected to the National Academy of Sciences (2008.05.13)
• "Through the Kitchen" Dinner at The Four Seasons Raises Record $550,000 for Cancer Research Institute (2008.05.05)
• Milestone: Therapeutic Kidney Cancer Vaccine Approved (2008.04.15)
• Howard Hughes Medical Institute Features CRI Scientific Advisory Council Associate Director James P. Allison, Ph.D.  (2008.01.31)
• Cancer Vaccine Consortium and Cancer Vaccine Collaborative Unite under Cancer Research Institute to Form Leading Initiative in Cancer Immunotherapy Research and Development  (2008.01.28)

2007

• Cancer Research Institute Named in Top 100 Charities by Givespot.com (2007.12.11)
• Immune System Controls Cancer, Promotes Tumor Dormancy (2007.11.18)
• Cancer Research Institute and Irvington Institute for Immunological Research Merge (2007.10.31)
• Forbes Features CRI Scientists in Story on New Melanoma Therapy (2007.10.15)
• CRI Scientist Named 2007 Albert Lasker Award Winner (2007.09.19)
• BGC Partners Names CRI Beneficiary of 9/11 Charity Day Event (2007.08.20)
• The Irvington Institute for Immunological Research and Cancer Research Institute Announce Intent to Merge; CRI to Assume Leadership of Combined Organization (2007.08.20)
• Ovarian Cancer Vaccine Induces Integrated Immune Response, Delays Recurrence in Patients (2007.07.31)
• The Drive Against Prostate Cancer Mobile Cancer Screening Clinic at CRI Awards Dinner (2007.06.18)
• Charity Watchdog Rates CRI "Best of the Best" (2007.06.08)
• New Cancer Vaccine to Enter Phase III Clinical Trial in Largest Lung Cancer Study Ever (2007.06.05)
• 2007 Grace and Coley Award Winners Announced (2007.05.18)
• First Melanoma Vaccine for Dogs Approved by USDA (2007.03.26)
• Immune Response to Cancer Stem Cells May Dictate Cancer’s Course (2007.03.26)
• CIBC World Markets Donates $85,000 to CRI Pediatric Cancer Initiative (2007.02.23)

2006

• A Promising New Vaccination Strategy for Late-Stage Melanoma (2006.09.20)
• Annual Cancer Research Institute Awards Dinner Raises $1 million (2006.06.27)
• Cervical Cancer Vaccine Approved (2006.06.08)
• CRI Executive Director Weighs in on Remarkable Cancer Proof Mouse (2006.06.07)
• Lung Cancer Vaccine Trial Results Bolster Pharma Giant GSK’s Interest in Targeted Immunotherapy; Major Licensing Deal Struck with CRI Partner (2006.06.04)
• Unraveling the Riddle of the Remarkable Mouse: New Collaborative Research Network Seeks Cause of Innate Cancer Immunity (2006.05.08)
• CRI Scientist, Creator of Cervical Cancer Vaccine, Given Australia’s Top Honor (2006.02.15)
• More Collaboration Between Pharma, Government, and Academia Required to Advance Cancer Immunotherapy, Says CRI Scientific Advisor (2006.01.31)

Looking for older releases?

• CRI Funding Leads to Vaccine That Prevents Cervical Cancer
• The Drive Against Prostate Cancer Heads to Louisiana to Aid in Hurricane Katrina Relief
• Scientist First to Discover How to Overturn Suppressive Immune Response
• Role of IFN alpha-beta in Cancer Immunoediting Identified
• Molecular Make-Up of Vaccine-Induced Cytotoxic T Lymphocytes Studied
• Study of Natural Killer T Cells in the Liver Yields Surprising Findings
• Clinical Trial Tests Promising New Melanoma Cancer Vaccines
• The Scientist’s NYC Supplement Features Top-Cited NYC Scientists
• CVC Touted as “Mini-Manhattan Project”
• Collaborative Approach of CVC Highlighted in Oncology Times
• Vaccine Holds Promise for Treatment of Melanoma
• CVC Trial Highlighted in National Magazine
• Antibody Therapy Rituximab Shows Potential as Treatment for Lymphoma
• CRI Scientist Featured
• Prevention Post Highlights Work of William B. Coley, M.D.
• Invariant Natural Killer T-Cell Responsiveness Studied
• Mechanism for T-Cell Neutralization in Melanoma Patients Studied
• Destruction of Antigen Loss Variants Cited as Key Mechanism to Control Cancer
• Cancer Vaccine Study Yields First Confirmation of Integrated Immunological Response